} ?>
31 stocks received institutional buy ratings today, and 5 stocks were paid attention to by institutions for the first time.
According to the statistics of Securities Times and Databao, a total of 34 buy rating records were issued in today's institutional research reports, involving a total of 31 stocks. Aibo Medical has received the highest attention, with a total of 3 institutional buy ratings.
A total of 9 of the stocks with institutional buy ratings today have given future price targets to the relevant stocks. Comparison with the latest closing price of the announced forecast target price shows that a total of 7 shares have an upside of more than 20%, and the industrial Fortune Union has the highest upside, on February 7, Huatai Securities expects the company's target price to be 37.20 yuan, with an upside of 72.62%, and stocks with higher upside are Kweichow Moutai, CIMC, etc., with an upside of 42.55% and 30.43% respectively.
From the perspective of institutional rating changes, among today's institutional buy rating records, there are 5 rating records that institutions have paid attention to for the first time, involving 5 stocks such as Palin Biotech and Shanghai Pudong Development Bank.
In terms of market performance, stocks with institutional buy ratings rose an average of 2.11% today, outperforming the Shanghai Composite Index. There are 24 stock prices that have risen, and there are Wolong electric drives. The top gainers are Ruoyuchen, Zhongji Innolight, Jingzhida, etc., with today's gains of 7.21%, 6.71%, and 5.97% respectively. Stocks with large declines include Nine Company, Shanghai Pudong Development Bank, Bank of Hangzhou, etc., with declines of 2.77%, 0.86%, and 0.47% respectively.
In terms of performance, 7 stocks have been announced by institutions to buy stocks, and the net profit growth rate is higher than that of Babi Food, Aibo Medical, and Shanghai Pudong Development Bank, with an increase of 29.64%, 27.36%, and 23.31% respectively. A total of 14 announced the annual performance forecast, in terms of the median net profit growth, the highest net profit growth is CIMC, the company is expected to increase the annual performance net profit by 612.00% year-on-year, followed by Goertek, Zhongji Innolight, etc., the median net profit growth rate is expected to be 145.00% and 139.25% respectively.
From the perspective of industries, machinery and equipment, food and beverage and other industries are the most favored, with 4 stocks on the list of institutional buy ratings. Banking, medicine and biology and other industries are also more concerned by institutions, with 4 and 3 stocks on the list respectively. (Data Treasure).
Institutional buy rating record today
Code | Abbreviation | Name of the institution | Latest ratings | Last rating | Forecast < BR/> target price (yuan). | The latest closing < BR/> price (yuan). |
---|---|---|---|---|---|---|
600519 | Kweichow Moutai | Dongxing Securities | Highly recommended | Highly recommended | 2047.00 | 1436.00 |
688050 | Aibo Medical | Haitong Securities | Better than the market | Better than the market | 108.16 | 96.29 |
600132 | Chongqing beer | Hua Chuang Securities | Strong push | Strong push | 67.00 | 55.20 |
601138 | Fortune Federation of Industries | Huatai Securities | Buy-in | Buy-in | 37.20 | 21.55 |
000403 | Palin Bio | CICC | Outperform the industry | Not rated | 25.50 | 21.65 |
300772 | Yunda shares | CICC | Outperform the industry | Outperform the industry | 15.89 | 12.77 |
600000 | Shanghai Pudong Development Bank | Haitong Securities | Better than the market | Not rated | 12.75 | 10.34 |
000039 | CIMC | Huatai Securities | Buy-in | Buy-in | 10.50 | 8.05 |
603323 | Sunon Bank | Huatai Securities | Buy-in | Buy-in | 6.38 | 5.31 |
688333 | BLT | Zheshang Securities | Overweight | Overweight | 53.53 | |
688627 | Jingzhida | Founder Securities | Recommended | Recommended | 84.99 | |
689009 | Company Nine | China Merchants Securities | Highly recommended | Highly recommended | 50.88 | |
605338 | Babi Foods | Great Wall Securities | Buy-in | Buy-in | 17.90 | |
688050 | Aibo Medical | Founder Securities | Recommended | Recommended | 96.29 | |
688050 | Aibo Medical | Guosheng Securities | Buy-in | Buy-in | 96.29 | |
601665 | Qilu Bank | Changjiang Securities | Buy-in | Buy-in | 5.88 | |
000528 | Liugong | Great Wall Securities | Buy-in | Buy-in | 11.05 | |
000625 | Changan Automobile | Donghai Securities | Buy-in | Buy-in | 13.54 | |
000625 | Changan Automobile | Minsheng Securities | Recommended | Recommended | 13.54 | |
000893 | Potassium International | Guosen Securities | Better than the market | Better than the market | 21.11 | |
001328 | Dengkang Oral Cavity | Tianfeng Securities | Overweight | Overweight | 33.78 | |
002241 | Goertek shares | Great Wall Securities | Overweight | Overweight | 29.43 | |
002572 | Sophia | Huafu Securities | Buy-in | Not rated | 15.88 | |
002601 | Longbai Group | Dongxing Securities | Highly recommended | Highly recommended | 18.03 | |
002984 | Mori Kirin | Shenwan Hongyuan | Overweight | Overweight | 25.29 | |
003010 | Ruo Yuchen | Shenwan Hongyuan | Buy-in | Not rated | 30.50 | |
300308 | Zhongji Innolight | Great Wall Securities | Buy-in | Buy-in | 107.78 | |
600079 | Humanwell Pharmaceutical | Great Wall Securities | Overweight | Not rated | 21.67 | |
300782 | Zhuo Sheng Wei | Great Wall Securities | Overweight | Overweight | 84.36 | |
301061 | Ingenuity in the home | Shenwan Hongyuan | Buy-in | Buy-in | 79.11 | |
600580 | Wolong electric drive | Guosen Securities | Better than the market | Better than the market | 26.54 | |
600872 | Zhongju high-tech | BOC Securities | Overweight | Overweight | 21.20 | |
600926 | Bank of Hangzhou | Zhongtai Securities | Overweight | Overweight | 14.70 | |
601088 | China Shenhua | Xiangcai Securities | Overweight | Overweight | 38.89 |
Note: This article is a news report and does not constitute investment advice, the stock market is risky, and investment should be cautious.
Ticker Name
Percentage Change
Inclusion Date